Companies / Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc.

Nasdaq: INBXCIK 2007919LA JOLLA, CA

Financials · FY2025

Revenue$1.30M
Net income$-140.06M
Total debt$176.28M
Cash$133.34M
Diluted EPS$-9.04
Shares outstanding14.7M

Ownership

14.7M shares outstanding · as of May 8, 2026
5.2%10%+ / strategic
Ownership
10%+ / strategic5.24%768,130
Institutions83.96%12,318,507
Public float10.80%1,584,549

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Forsyth DouglasDirector
——
Kayyem Jon FaizDirector
——
Manhard KimberlyDirector
——

Institutional holders 141

View all →
HolderValue% of shares
Perceptive Advisors LLC$96.99M9.83%
Viking Global Investors LP$96.66M9.80%
Morgan Stanley$92.25M7.96%
BlackRock, Inc.$78.26M5.63%
Sanofi$77.85M7.89%
HighTower Advisors, LLC$68.77M5.93%
State Street Corporation$60.68M4.37%
Vanguard Group Inc$49.22M4.25%
Sofinnova Investments, Inc.$35.92M3.10%
Capital Research Global Investors$33.30M2.87%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 3, 2026Kayyem Jon Faiz
Director
GrantStock Option (right to buy)—+15K
15,000
0.10% of shares
low
Jun 3, 2026Forsyth Douglas
Director
GrantStock Option (right to buy)—+15K
15,000
0.10% of shares
low
Jun 3, 2026Manhard Kimberly
Director
GrantStock Option (right to buy)—+15K
15,000
0.10% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Viking Global Investors LPPassive13G/A———
BlackRock, Inc.Passive13G—768,130—
Morgan StanleyPassive13G———
Viking Global Investors LPPassive13G/A———
Perceptive Advisors LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
INBX——45720N103—